Ventricular tachycardia after application of erythromycin in a newborn with congenital complete AV-Block;Ventrikulare tachykardie nach erythromycin-gabe bei einem neugeborenen mit angeborenem av-block

Klinische Padiatrie

Volumn 211, Issue 6, 1999, Pages 465-468

  Brixius, Benedikt ^a   Lindinger, Angelika ^a   Baghai, A ^a   Limbach, H G ^a   Hoffmann, W ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Congenital complete av block; Erythromycin; Torsades de pointe; Ventricular tachycardia

Indexed keywords

ERYTHROMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CASE REPORT; COLLAGEN DISEASE; DISEASE ASSOCIATION; HEART VENTRICLE TACHYCARDIA; HUMAN; NEWBORN; CHEMICALLY INDUCED DISORDER; ELECTROCARDIOGRAPHY; HEART BLOCK; INTRAVENOUS DRUG ADMINISTRATION; MALE; PATHOPHYSIOLOGY; SEPSIS; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ELECTROCARDIOGRAPHY; ERYTHROMYCIN; HEART BLOCK; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; SEPSIS; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 0033219850     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043836     Document Type: Article

References (21)

1. 1 Antezelevich, C., Z. Q. Sun, Z. Q. Zhang, G. X. Yan: Celluar and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. J. Am. Coll. Cardiol. 28 (1996) 1836-1848
2. 2 Behan, W. M. H., P. O. Behan, J. M. Reid, W. Doig, J. Gairns: Family studies of congenital heart block associated with Ro antibody. Br. Heart J. 62 (1989) 320-324
3. 3 Benoit, A., C. Bodin, E. Villain, F. Bavoix, A. Checoury, J. Badoual: QT-Prolongation and circulary arrest after an injection of erythromycin in a newborn infant. Arch. Fr. Pediatr. 48 (1991) 39-41
4. 4 Brandriss, M. W., W. S. Richardson, S. S. Barold: Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsade de pointes): case report and review. Clin. Infect. Dis. 18 (1994) 995-998
5. 5 Camilleri, J. F., J. C. Deharo, D. Pangides, D. Broin, T. Mesana, D. Blin, A. Mouly-Bandini, C. Dubouloz, A. Goudard, J. R. Monties: Jet intravenous injection of Erythromycine lactibionate. A possible cause of the occurrence of crisis in torsade des pointes. An. Cardiol. Angeiol. Paris 38 (1989) 657-659
6. 6 Chameides, L., L. C. Truex, V. Vetter: Association of maternal systemic lupus erythematosus with congenital complete heart block. N. Engl. J. Med. 297 (1977) 1204-1207
7. 7 Daleau, P., E. Lessard, M.-F. Groleau, J. Turgeon: Erythromycin blocks the rapid component of the delayed rectifir potassium current and lengthens repolarisation of guinea pig ventricular myocytes. Ciculation 91 (1995) 3010-3016
8. 8 de Koning, J., H. van-der Hoeve, B. Hamer, J. Thompsen: Erythomycin-induced torsade de pointes and ventricular fibrillation in a patient with legionella pneumonia. Neth. J. Med. 44 (1994) 131-135
9. 9 Haefeli, W. E., R. A. Schoenenberger, P. Weiss, R. Ritz: Possible risk for cardiac arrhythmia related to intravenous Erythromycin. Intensive care Med. 18 (1992) 469-473
10. 10 Harley, J. B., J. L. Kaine, O. F. Fox, M. Reichlin, B. Gruber: Ro (SS-A) antibody and antigen in a patient with congenital complete heart block. Arthritis Rheum. 28 (1985) 1321-1325
11. 11 McCue, C. M., M. E. Mantakas, J. B. Tingelstad, S. Ruddy: Congenital heart block in newborns of mothers with connective tissue disease. Circulation 56 (1977) 82-90
12. 12 Michaelsson, M., M. A. Engle: Congenital complete heart block: An international study of the natural history. Cardiovasc. Clin. 4 (1972) 8-101
13. 13 Oberg, K. C., J. L. Bauman: QT interval prolongation and torsades de pointes due to erythromycin lactobionate. Pharmacotherapy 15 (1995) 687-692
14. 14 Olsen, N. Y., C. B. Lindsley: Neonatal lupus syndrome. Am. J. Dis. Child. 141 (1987) 908-910
15. 15 Pinsky, W. W., P. C. Gillette, A. Garson, D. G. McNamara: Diagnosis, management, and long-term results of patients with congenital complete atrioventricular block. Pediatrics 69 (1982) 728-733
16. 16 Ponsonaille, J., B. Citron, A. Richard, J. F. Trolese, A. Chaperon, B. Barret, H. Gras: Electrophysiological study of pro-arrhythmogenic effects of Erythromycin. Arch. Mal. Coeur Vaiss. 81 (1988) 1001-1008
17. 17 Ross, B. A., W. W. Pinsky, D. J. Driscoll: Complete atrioventricular block. Pediatric arrhythmias: Electrophysiology and pacing. Saunders, Philadelphia, pp. 306-316 (1990)
18. 18 Rubart, M., M. L. Pressler, H. P. Pride, D. P. Zipes: Electrophysiological mechanisms in a canine model of Erythromycin associated long OT syndrome. Circulation 88 (1993) 1832-18
19. 19 Solt, Z., L. L. MacDonald, M. A. Peters, B. Guslits: Erythromycin-induced cardiac toxicity. Am. J. Cardiol. 75 (1995) 859-861
20. 20 Taylor, P. V., J. S. Scott, L. M. Gerlis: Maternal antibodies against fetal cardiac antigens in congenital complete heart block. N. Engl. J. Med. 315 (1986) 667-672
21. 21 Tschida, S. J., D. R. Guay, R. J. Straka, L. L. Hoey, R. Johanning, K. Vance-Bryun: QTc-Intervall prolongation associated with slow intravenous erythromycin lactobionate infilsions in critically ill patients: a prospective evaluation and review of literature. Pharmacotherapy 16 (1996) 663-674 Dr. med. Benedikt Brixius Abteilung für pädiatrische Kardiologie Universitätsklinik für Kinder und Jugendmedizin D-66421 Homburg/Saar